Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study on the Safety and Effectiveness of Tramadol 37.5mg/Actaminophen 325mg Versus Gabapentin in Diabetic Neuropathic Pain
This study has been completed.
Study NCT00634543 Information provided by Janssen Korea, Ltd., Korea
First Received: March 6, 2008 Last Updated: July 10, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Diabetic Neuropathies
More general conditions related to this trial
Diabetes Complications
Diabetes Mellitus
Endocrine System Diseases
Nervous System Diseases
Neuromuscular Diseases
Peripheral Nervous System Diseases
Additional drug interventions recognized in this trial
Acetaminophen
Gabapentin
Tramadol
More general drug interventions related to this trial
Analgesics
Analgesics, Non-Narcotic
Analgesics, Opioid
Anti-Anxiety Agents
Anti-Dyskinesia Agents
Anticonvulsants
Antimanic Agents
Antiparkinson Agents
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Excitatory Amino Acid Agents
Excitatory Amino Acid Antagonists
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Narcotics
Neurotransmitter Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Sensory System Agents
Therapeutic Uses
Tranquilizing Agents
Sponsors listed in this trial
Janssen Korea, Ltd., Korea
Back to top of Main Content
